Acute pancreatitis in a girl with panhypopituitarism due to craniopharyngioma on growth hormone treatment. A combination of risk factors

Maria Felicia Faienza, Maurizio Delvecchio, Flavia Indrio, Ruggiero Francavilla, Angelo Acquafredda, Luciano Cavallo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Craniopharyngioma is a rare, benign, suprasellar brain tumor associated with a significant number of endocrine and metabolic impairments. Growth hormone deficiency, caused by the tumor itself or by its subsequent surgical treatment, is the most common hormone deficiency in these patients and replacement is frequently necessary. Hypothalamic obesity observed after surgery treatment, whether combined with radiotherapy or not, presents with increased abdominal fat and altered lipid profiles and is likely caused by both disruption of the mechanisms controlling satiety, hunger and energy balance and impairment of sensitivity to leptin, insulin and ghrelin axis. It is well known that hyperlipemia is associated with acute pancreatitis, both as a precipitant and as an epiphenomenon. Moreover, the increased incidence of acute pancreatitis during growth hormone therapy is possibly due to increased enzyme production (e.g., amylase, lipase and elastase). We report the case of a 13-year-old girl affected by craniopharyngioma on growth hormone replacement treatment who developed acute pancreatitis. We suggest including routine evaluation of lipid profile during follow-up of all children on growth hormone treatment, especially those affected by hypopituitarism secondary to craniopharyngioma, given pancreatic adverse effects of growth hormone replacement therapy and associated metabolic impairment due to hypothalamic obesity.

Original languageEnglish
Pages (from-to)372-375
Number of pages4
JournalHormone Research
Volume71
Issue number6
DOIs
Publication statusPublished - Jun 2009

Fingerprint

Craniopharyngioma
Pancreatitis
Growth Hormone
Obesity
Lipids
Therapeutics
Abdominal Fat
Hypopituitarism
Ghrelin
Hunger
Pancreatic Elastase
Hormone Replacement Therapy
Amylases
Leptin
Hyperlipidemias
Lipase
Brain Neoplasms
Radiotherapy
Combined Pituitary Hormone Deficiency
Hormones

Keywords

  • Craniopharyngioma
  • Growth hormone
  • Hyperlipemia
  • Obesity
  • Pancreatitis

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Acute pancreatitis in a girl with panhypopituitarism due to craniopharyngioma on growth hormone treatment. A combination of risk factors. / Faienza, Maria Felicia; Delvecchio, Maurizio; Indrio, Flavia; Francavilla, Ruggiero; Acquafredda, Angelo; Cavallo, Luciano.

In: Hormone Research, Vol. 71, No. 6, 06.2009, p. 372-375.

Research output: Contribution to journalArticle

Faienza, MF, Delvecchio, M, Indrio, F, Francavilla, R, Acquafredda, A & Cavallo, L 2009, 'Acute pancreatitis in a girl with panhypopituitarism due to craniopharyngioma on growth hormone treatment. A combination of risk factors', Hormone Research, vol. 71, no. 6, pp. 372-375. https://doi.org/10.1159/000223423
Faienza, Maria Felicia ; Delvecchio, Maurizio ; Indrio, Flavia ; Francavilla, Ruggiero ; Acquafredda, Angelo ; Cavallo, Luciano. / Acute pancreatitis in a girl with panhypopituitarism due to craniopharyngioma on growth hormone treatment. A combination of risk factors. In: Hormone Research. 2009 ; Vol. 71, No. 6. pp. 372-375.
@article{1b289aba001146e69ac7aac5849a00fd,
title = "Acute pancreatitis in a girl with panhypopituitarism due to craniopharyngioma on growth hormone treatment. A combination of risk factors",
abstract = "Craniopharyngioma is a rare, benign, suprasellar brain tumor associated with a significant number of endocrine and metabolic impairments. Growth hormone deficiency, caused by the tumor itself or by its subsequent surgical treatment, is the most common hormone deficiency in these patients and replacement is frequently necessary. Hypothalamic obesity observed after surgery treatment, whether combined with radiotherapy or not, presents with increased abdominal fat and altered lipid profiles and is likely caused by both disruption of the mechanisms controlling satiety, hunger and energy balance and impairment of sensitivity to leptin, insulin and ghrelin axis. It is well known that hyperlipemia is associated with acute pancreatitis, both as a precipitant and as an epiphenomenon. Moreover, the increased incidence of acute pancreatitis during growth hormone therapy is possibly due to increased enzyme production (e.g., amylase, lipase and elastase). We report the case of a 13-year-old girl affected by craniopharyngioma on growth hormone replacement treatment who developed acute pancreatitis. We suggest including routine evaluation of lipid profile during follow-up of all children on growth hormone treatment, especially those affected by hypopituitarism secondary to craniopharyngioma, given pancreatic adverse effects of growth hormone replacement therapy and associated metabolic impairment due to hypothalamic obesity.",
keywords = "Craniopharyngioma, Growth hormone, Hyperlipemia, Obesity, Pancreatitis",
author = "Faienza, {Maria Felicia} and Maurizio Delvecchio and Flavia Indrio and Ruggiero Francavilla and Angelo Acquafredda and Luciano Cavallo",
year = "2009",
month = "6",
doi = "10.1159/000223423",
language = "English",
volume = "71",
pages = "372--375",
journal = "Hormone Research",
issn = "0301-0163",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Acute pancreatitis in a girl with panhypopituitarism due to craniopharyngioma on growth hormone treatment. A combination of risk factors

AU - Faienza, Maria Felicia

AU - Delvecchio, Maurizio

AU - Indrio, Flavia

AU - Francavilla, Ruggiero

AU - Acquafredda, Angelo

AU - Cavallo, Luciano

PY - 2009/6

Y1 - 2009/6

N2 - Craniopharyngioma is a rare, benign, suprasellar brain tumor associated with a significant number of endocrine and metabolic impairments. Growth hormone deficiency, caused by the tumor itself or by its subsequent surgical treatment, is the most common hormone deficiency in these patients and replacement is frequently necessary. Hypothalamic obesity observed after surgery treatment, whether combined with radiotherapy or not, presents with increased abdominal fat and altered lipid profiles and is likely caused by both disruption of the mechanisms controlling satiety, hunger and energy balance and impairment of sensitivity to leptin, insulin and ghrelin axis. It is well known that hyperlipemia is associated with acute pancreatitis, both as a precipitant and as an epiphenomenon. Moreover, the increased incidence of acute pancreatitis during growth hormone therapy is possibly due to increased enzyme production (e.g., amylase, lipase and elastase). We report the case of a 13-year-old girl affected by craniopharyngioma on growth hormone replacement treatment who developed acute pancreatitis. We suggest including routine evaluation of lipid profile during follow-up of all children on growth hormone treatment, especially those affected by hypopituitarism secondary to craniopharyngioma, given pancreatic adverse effects of growth hormone replacement therapy and associated metabolic impairment due to hypothalamic obesity.

AB - Craniopharyngioma is a rare, benign, suprasellar brain tumor associated with a significant number of endocrine and metabolic impairments. Growth hormone deficiency, caused by the tumor itself or by its subsequent surgical treatment, is the most common hormone deficiency in these patients and replacement is frequently necessary. Hypothalamic obesity observed after surgery treatment, whether combined with radiotherapy or not, presents with increased abdominal fat and altered lipid profiles and is likely caused by both disruption of the mechanisms controlling satiety, hunger and energy balance and impairment of sensitivity to leptin, insulin and ghrelin axis. It is well known that hyperlipemia is associated with acute pancreatitis, both as a precipitant and as an epiphenomenon. Moreover, the increased incidence of acute pancreatitis during growth hormone therapy is possibly due to increased enzyme production (e.g., amylase, lipase and elastase). We report the case of a 13-year-old girl affected by craniopharyngioma on growth hormone replacement treatment who developed acute pancreatitis. We suggest including routine evaluation of lipid profile during follow-up of all children on growth hormone treatment, especially those affected by hypopituitarism secondary to craniopharyngioma, given pancreatic adverse effects of growth hormone replacement therapy and associated metabolic impairment due to hypothalamic obesity.

KW - Craniopharyngioma

KW - Growth hormone

KW - Hyperlipemia

KW - Obesity

KW - Pancreatitis

UR - http://www.scopus.com/inward/record.url?scp=66449134013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66449134013&partnerID=8YFLogxK

U2 - 10.1159/000223423

DO - 10.1159/000223423

M3 - Article

VL - 71

SP - 372

EP - 375

JO - Hormone Research

JF - Hormone Research

SN - 0301-0163

IS - 6

ER -